[CIS-PAGID] NZ infant with PJP

[Brian P Vickery]

HIV PCR? 
___________________
Brian Vickery, MD
Division of Pediatric Allergy & Immunology
Duke University Medical Center
DUMC Box 2644, Durham NC 27710
919.681.2949

"Email should NOT be used for urgent medical issues. The information in 
this electronic mail is sensitive, protected information intended only for 
the addressee(s). Any other person, including anyone who believes he/she 
might have received it due to an addressing error, is requested to notify 
the sender immediately by return electronic mail, and to delete it without 
further reading or retention. The information is not to be forwarded to or 
shared unless in compliance with Duke Medicine policies on confidentiality 
and/or with the approval of the sender."






[CIS-PAGID] NZ infant with PJP

Jan Sinclair (ADHB) 
to:
pagid at list.clinimmsoc.org
04/27/2011 07:26 PM


Sent by:
pagid-bounces at list.clinimmsoc.org
Please respond to pagid






Dear PAGID members
 
Would appreciate any thoughts on a male infant, now 6 months old.   New 
Zealand born, South East Asian parents, non consanguineous. 1st child to 
this couple.   Early oral candida, responding to treatment but recurring 
each time treatment stopped. 
 
He presented at 3 months of age with: 
·          Pneumocystis pneumonia, problematic course needing prolonged 
intensive care stay, complicated by biopsy proven pulmonary alveolar 
proteinosis (managed with repeated pulmonary lavage), now well from a 
respiratory point of view.
·          Failure to thrive and chronic diarrhoea.  Negative for all GI 
pathogens (bacterial and viral including PCR), upper and lower scope with 
normal pathology on 2 occasions.  Diarrhoea improved with TPN and now 
gaining weight but unable to transition back to oral feeds. 
 
Investigations:
§         Thymus present on first CXR
§         Normal / raised lymphocyte count (most often 6-12 x 109/l)
§         No rash, no hepatosplenomegaly, and no adenopathy 
§         Mild metaphyseal dysplasia, skeletal survey otherwise no 
abnormality
§         Phenotype (repeated over time and essentially unchanged)
CD4      49    %           Absolute CD4      6138    X10E6/L
CD8      22    %           Absolute CD8      2755    X10E6/L
CD4:CD8 ratio      2.2
CD3      70    %           Absolute CD3      8823    X10E6/L
CD19      27    %         Absolute CD19      3451    X10E6/L
CD56      2    %           Absolute CD56      297    X10E6/L
§         TREC                                normal
§         Vb repertoire                     polyclonal
·          No maternal engraftment
·          Immunoglobulins               presentation    Feb      Mar Now
IgG                               1.7                   IVIG      IVIG  
IVIG
IgA                               0.29                 0.48     <0.07 0.11
IgM                               0.06                 1.8       0.17 0.12
·          CD40L normal
 
Proliferation:
At presentation                       PATIENT    CONTROL
                                    cpm                 SI     cpm  SI 
Background                 122                                          26
PHA                             1409                11.5 27539  1059.2
CON A                         1747                14.3 7265 279.4
CD3 Response           67                    0.5                   4696    
      180.6
 
On repeat testing these have improved markedly, most recently:
                                     PATIENT       SI Control          SI
Background                 432                                       70    
 
PHA                             138930         321                  111031 
        1586
T3                                16128           37 47781           683
PMA                             3931             9 9100             130
Ionomycin                    320               1                      238  
            3
PMA + Ionomycin        47755           110                  229807 3283
 
 
The initial thought was that he may have a T cell activation defect. 
Calcium flux studies were kindly undertaken by Prof Stefan Feske in New 
York, which were normal, excluding ORAI1 or STIM1 as the underlying 
defect.
 
Early in his course the plan was to consider HSCT, with good cord matches 
available.  We are currently not hurrying in that direction, with 
normalisation of his proliferation, a slew of other normal investigations, 
and no diagnosis.  However he is still TPN dependent and his 
immunoglobulin results suggest loss of IgA and M production.
 
Any thoughts (underlying defect / other investigations / treatment 
options) would be welcome. 
 
Dr Jan Sinclair
Paediatric Immunology
Starship Children’s Hospital
Auckland, New Zealand
Ph            (64 9) 307 8900 extension 6429
Fax          (64 9) 307 8977 (internal 5977)
Mobile      021 365 445
 

Scanned by MailMarshal - Marshal8e6's comprehensive email content security 
solution. Download a free evaluation of MailMarshal at www.marshal.com



-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://seven.pairlist.net/mailman/private/pagid/attachments/20110427/74c8973f/attachment.html>